EYPT:NASDAQ
EyePoint Inc
US$ 3.85
arrow_downward
-3.51%(-0.14) Siku 1
US$ 3.90
arrow_upward
+1.30% (+0.050)bedtimeBaada ya saa
Imefungwa: 18 Sep, 16:00:02 GMT -4 · USD
search
Alama zote
Siku 1
Siku 5
Mwezi 1
Miezi 6
YTD
Mwaka 1
Miaka 5
ISIZIDI
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EYPT...
Fungua
US$ 3.95
Juu
US$ 4.06
Chini
US$ 3.77
Mtaji wa soko
331.92M
Wastani wa kiasi cha mauzo
5.84M
Kiasi cha mauzo ya hisa
7.27M
Juu kwa wiki 52
US$ 19.01
Chini kwa wiki 52
US$ 3.42
EPS
-US$ 3.74
Beta
1.63
Hisa za wawekezaji
86.21M
Idadi ya wafanyakazi
214
Fungua
US$ 3.95
Juu
US$ 4.06
Chini
US$ 3.77
Mtaji wa soko
331.92M
Wastani wa kiasi cha mauzo
5.84M
Kiasi cha mauzo ya hisa
7.27M
Juu kwa wiki 52
US$ 19.01
Chini kwa wiki 52
US$ 3.42
EPS
-US$ 3.74
Beta
1.63
Hisa za wawekezaji
86.21M
Idadi ya wafanyakazi
214
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Benzinga
·
saa 18 zilizopita
Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
CarePlus VietNam
·
mwezi 1 uliopita
EyePoint Pharmaceuticals' Duravyu Fails Late-Stage Eye Disease Trial, Shares Plunge 70% - Revenue Estimate Trend
Wasifu
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. In December 2025, the company changed its corporate name to EyePoint, Inc. Wikipedia
Kuhusu EyePoint Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi214
Lilianzishwa2000
Makao makuuWatertown, Massachusetts, Marekani
Sekta-
Tovutieyepoint.bio